lecture 4 - communication at the synapse 2 Flashcards
biogenic amines neurotransmitters
-dopamine
-serotonin
-histamine
-adrenaline/epinephrine
-noradrenaline/norepinephrine
-all small molecule neurotransmitters
-similar structures
-widespread in the brain (so if prescribed a drug that acts on these, you should be aware side effects can be widespread)
unconventional neurotransmitters
endocannabinoids
serotonin
-structure
-where is most of this
-where is it produced
-its roles
-90% serotonergic signalling is in gut
(works to have an effect on digestion)
-10% serotonergic neurons in the brain
-produced in the pons and upper brainsteam (raphe nuclei) , it has projections to the forebrain
-roles: regulation of mood, appetite and sleep, also involved in memory and learning
serotonin cascade
-serotonin precursor
-single neurotransmitter from its precursors to its final version
-serotonin precursor is tryptophan, mainly taken in by our diet eg oats, fish, cheese
-tryptophan converted to 5htp and then converted to serotonin
-packaged into vesicles, released from the presynaptic neuron to receptors on post synaptic neuron
-action potential which arrives at presynaptic neuron causes cell to release
-
depression and monoamines
key features
-intense feelings of sadness, helplessness and hopelessness
-anhedonia- general lack of interest that you would usually enjoy
-tiredness, lack of energy
-abnormal sleep and eating patterns
-cognitive impairments: concentrations, memory, executive function
the monoamine hypothesis
-how did we come about linking depression to monoamines
-came about from observing side effects of drugs
-reserpine (hypertension medication)
-in 1960s people who took this for blood pressure started to develop depression symptoms (micheals and gibbon 1963)
what is reserpine
-how can it explain monoamines link to depression
-reserpine is antagonist (which reduce normal action of drug) of the monoamines
-so suggests that monoamines are to low in patients who have depression
-reserpine prevents monoamines from being packaged into the vesicles , so nothing to release and so less monoamine action
what category of drug may be used in treatment of depression
agonists - antidepressants
types of antidepressants
-monoamine oxidase inhibitors
-tricyclic antidepressants
-SSRIs
-SNRIs
monamine oxidase inhibitors (MAOIs)
-what does it do
-inhibit the activity of the enzyme called monoamine oxidase that normally breaks down monoamine NTs- dopamine, noradrenaline and serotonin
-so leaves more of the molecule you need
-have to be careful with diet since it can mess with noradrenaline
tricyclic antidepressants
-work on noradrenalin and serotonin
-block reuptake of noradrenaline and serotonin-increasing levels of these two NTs in the synapse
SSRIs
-selective serotonin reuptake inhibitors : first choice for treating depression
eg prozac
SNRIs
selective noradrenaline reuptake inhibitors
serotonin based treatments
-SSRis process
-side effects
-examples
-selective serotonin reuptake inhibitors block the channels that allow serotonin to be removed from the cleft
-side effects :due to high levels of serotonin receptors in the GI tract, side effects of treatments can include weight loss, nausea and diarrhoea
-prozac fluoxetine are examples
agonists _____ serotonin action
enhance
does depression occur only due to low serotonin
moncrieff 2022
-paper found no strong evidence for lowered serotonin actions in depressed patients compared to controls
-royal collge of psychiatrists 2019
saying that ‘anti depressants correct a chemical imbalance is an over simplification’